NGM Biopharmaceuticals Inc (NGM) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NGM Biopharmaceuticals, Inc. was notified by Nasdaq on January 18, 2024, that it has regained compliance with the minimum bid price requirement after its common stock’s closing bid price remained at $1.00 or above from January 2 to January 17, 2024. Consequently, the issue concerning its non-compliance with Nasdaq Listing Rule 5450(a)(1) has been resolved and the matter is closed.
For further insights into NGM stock, check out TipRanks’ Stock Analysis page.
